Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/1995
09/19/1995US5451609 Deacetly moxisylyte
09/19/1995US5451572 Human relaxin formulation
09/19/1995US5451411 Polyacrylic acid, crosslinked alginate
09/19/1995US5451407 Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
09/19/1995US5451397 Crosslinked amino functional acrylic amide polymer, reducing blood cholesterol levels
09/19/1995US5451205 Remove and store portion of blood of patient, administer biocompatible oxygen carrier, return blood after patient has blood loss
09/16/1995CA2144591A1 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
09/14/1995WO1995024489A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995WO1995024430A2 Block and graft copolymers and methods relating thereto
09/14/1995WO1995024418A1 Method of isolating and purifying a biomacromolecule
09/14/1995WO1995024417A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof
09/14/1995WO1995024221A1 Bioactive and/or targeted dendrimer conjugates
09/14/1995WO1995024220A1 Bispecific molecules having clinical utilities
09/14/1995WO1995024219A1 Veterinary formulation
09/14/1995WO1995024193A1 Topical preparations
09/14/1995WO1995024188A1 Slow-release tablet containing diclofenac-na
09/14/1995WO1995024187A1 Plaster-shaped transdermal system with a tamoxifen derivative
09/14/1995WO1995024184A1 Gas filled microspheres as magnetic resonance imaging contrast agents
09/14/1995WO1995024183A1 Methods and compositions for pulmonary delivery of insulin
09/14/1995WO1995024179A1 LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
09/14/1995DE4408326A1 Retardtablette mit einem Gehalt an Diclofenac-Na Release tablet containing diclofenac-Na
09/14/1995DE4407995A1 Topische Zubereitungen Topical preparations
09/14/1995CA2185231A1 Low ph, hydrolytically stable, cosmetic compositions containing acidic actives
09/14/1995CA2185117A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
09/14/1995CA2185016A1 Transdermal system in the form of a patch comprising a tamoxifen derivative
09/14/1995CA2184994A1 Veterinary formulation
09/14/1995CA2184814A1 Block and graft copolymers and methods relating thereto
09/14/1995CA2183898A1 Nucleotide or nucleosidephotoaffinity compound modified antibodies, methods for their manufacture and use thereof as diagnostics and therapeutics
09/13/1995EP0671429A1 Dense star polymers and a process for producing dense star polymers
09/13/1995EP0671412A1 Tumor cell invasion-inhibiting peptides and cancer metastasis inhibitors
09/13/1995EP0671175A2 Sustained release compositions for treating periodontal disease
09/13/1995EP0671169A1 Nanoparticles containing an active agent and a cetal-tartanic acid amides polymer, process for preparation thereof and their use
09/13/1995EP0671168A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
09/13/1995EP0671167A1 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
09/13/1995EP0671165A2 Collagen-based injectable drug delivery system and its use
09/13/1995EP0671162A2 Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use
09/13/1995EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor
09/13/1995EP0670728A1 Lipophilic peptide-based carriers for targeted drug delivery using rational drug-binding design
09/13/1995EP0670725A1 Pharmaceutical compositions for use in gastrointestinal washes
09/13/1995EP0670716A1 Tastemasked pharmaceutical materials
09/13/1995EP0670714A1 Retinoic acid-containing compositions
09/13/1995EP0670713A1 A pharmaceutical formulation
09/13/1995EP0644746A4 The use of glycerin in moderating transdermal drug delivery.
09/13/1995EP0529002A4 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes
09/13/1995CN1108454A Anthracycline conjugates, their preparation and their use as antitumor agents
09/13/1995CN1108137A Pharmaceutical compositions
09/12/1995US5449760 Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
09/12/1995US5449720 Amplification of the VB12 uptake system using polymers
09/12/1995US5449670 Composition and method for the transdermal delivery of bioactive peptides
09/12/1995US5449521 Supported drugs with increased dissolution rate, and a process for their preparation
09/12/1995US5449513 Physical trapping type polymeric micelle drug preparation
09/12/1995CA1336961C Long lasting composition of propafenone and quinidine for treatment of cardiac conditions
09/12/1995CA1336958C Peroral preparation of acid-unstable compound
09/12/1995CA1336957C Phospholipid-containing composition, a process for its preparation and its use as an excipient for pharmaceutical substances
09/10/1995CA2144216A1 Nanoparticles containing an active substance and a ketalized polytartramidic acid, process for their preparation, and use thereof
09/08/1995WO1995023854A1 IMPROVED DNase LIQUID SOLUTIONS
09/08/1995WO1995023846A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
09/08/1995WO1995023605A1 Method for treating and inhibiting gastric and duodenal ulcers
09/08/1995WO1995023601A1 Method and composition for topical treatment of damaged tissue using histamine phosphate as active ingredient
09/08/1995WO1995023600A1 Sublingual or buccal pharmaceutical composition
09/08/1995WO1995023593A1 Controlled release oxybutynin formulations
09/08/1995WO1995023591A1 Oral vehicle compositions
09/08/1995WO1995023586A2 Cosmetic and/or pharmaceutical preparations
09/08/1995CA2184354A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
09/08/1995CA2183329A1 Method for treating and inhibiting gastric and duodenal ulcers
09/07/1995DE4407015A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations
09/06/1995EP0670326A2 Crystalline maltosyl glucoside, and its production and use
09/06/1995EP0670166A2 Formulations for orally administered pharmaceutical agents
09/06/1995EP0670162A1 Pharmaceutical formulations containing raloxifere, a surfactant and a watersoluble diluent
09/06/1995EP0669988A1 Angiogenesis inhibitory antibodies
09/06/1995EP0669985A1 Conjugate vaccine against group b streptococcus
09/06/1995EP0669982A1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
09/06/1995EP0669941A1 Method of reducing multidrug resistance in cells and tissues
09/06/1995EP0669940A1 Specifically crosslinked hemoglobin with free functionality
09/06/1995EP0669927A1 Sequence-specific binding polymers for duplex nucleic acids
09/06/1995EP0669837A1 Restrained multifunctional reagent for surface modification
09/06/1995EP0629128B1 Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof
09/06/1995EP0617958A4 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions.
09/06/1995EP0561815B1 Directly compressible xylitol and method
09/06/1995EP0464040B1 A moderated spun fibrous system and method of manufacture
09/06/1995CN1107695A Plaster without lead and its preparation
09/05/1995US5447940 Reinforced collagen matrix, dispersed antibiotic, analgesic, antiinflammatory, antiseptic
09/05/1995US5447936 Anticarcinogenic agents in dimethylacetamide solutions and carboxylic acids
09/05/1995US5447912 Injecting the neuropeptides VIP and PHM and an adrenergic blocking agent
09/05/1995US5447728 A carrier comprising an acylated amino acid; lowering iron concentration in mammals
09/05/1995US5447726 Hydroxypropylmethylcellulose coating on anion exchange resin and silicon dioxide
09/05/1995US5447725 Methods for aiding periodontal tissue regeneration
09/05/1995CA2006425C Transdermal therapeutical system comprising norpseudoephedrine as active component
09/05/1995CA1336893C Reversibly precipitable, water-soluble polymer conjugates, their preparation and use in homogeneous catalysis
09/05/1995CA1336890C Amphotericin b/cholesterol sulfate composition and method
09/05/1995CA1336889C Treatment of iodine deficiency diseases
09/05/1995CA1336888C Urease antigen product & process
09/05/1995CA1336887C Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
09/02/1995CA2138607A1 Formulations for orally administered pharmaceutical agents
08/1995
08/31/1995WO1995023216A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
08/31/1995WO1995023214A1 Method for stimulating profileration of colon cells using pomc¿76-103?
08/31/1995WO1995022992A2 Method and compositions for increasing the serum half-life of pharmacologically active agents
08/31/1995WO1995022991A2 Block copolymers
08/31/1995WO1995022982A1 Cyclosporin-containing powder composition
08/31/1995WO1995022977A1 Antigen-based heteropolymers and method for treating autoimmune diseases using the same